Z

Zimmer Biomet Holdings, Inc. (ZBH)

NYQ – Real vaqt narxi. Valyuta: USD

83.37

+3.79 (4.76%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Z

Zimmer Biomet Holdings, Inc. (ZBH)

NYQ – Real vaqt narxi. Valyuta: USD

83.37

+3.79 (4.76%)

Yopilishda: May 12, 2026, 4:00 PM EDT

12.05.2026

Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End

WARSAW, Ind., May 12, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.

06.05.2026

Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference

WARSAW, Ind., May 6, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Bank of America Securities Health Care Conference on Wednesday, May 13, 2026, with a fireside chat at 8:40 a.m.

04.05.2026

Why Zimmer Biomet (ZBH) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

01.05.2026

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

29.04.2026

These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported upbeat earnings for the first quarter on Tuesday.

28.04.2026

Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported first-quarter adjusted earnings of $2.09 per share, up 15.5% year over year, beating the Street estimates of $1.86.

28.04.2026

Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call Transcript

Videolar

12.08.2025

Positive

4 Stocks to Buy From a Top-Performing Fund Manager

Press-relizlar

12.05.2026

Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End

WARSAW, Ind., May 12, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.

28.04.2026

Zimmer Biomet Announces First Quarter 2026 Financial Results

First quarter net sales of $2.087 billion increased 9.3% on a reported basis, 6.8% on a constant currency1 basis and 2.9% on an organic constant currency1 basis First quarter diluted earnings per share were $1.22, an increase of 34.1%; adjusted1 diluted earnings per share were $2.09, an increase of 15.5% Company updates full-year 2026 financial guidance WARSAW, Ind., April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2026.

28.04.2026

Zimmer Biomet Announces Chief Financial Officer Transition

Suketu Upadhyay to Depart; Paul Stellato Named Interim CFO WARSAW, Ind., April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced Suketu Upadhyay, Chief Financial Officer and Executive Vice President, Finance, Operations and Supply Chain, will depart the company effective April 28 for a new professional opportunity.

07.04.2026

Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer

Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company in an elevated capacity WARSAW, Ind., April 7, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Jonathan M.

Search stocks

Zimmer Biomet Holdings, Inc. (ZBH)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End

Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference

Why Zimmer Biomet (ZBH) is a Top Growth Stock for the Long-Term

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results

Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday?

Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call Transcript

Videolar

Press-relizlar

Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End

Zimmer Biomet Announces First Quarter 2026 Financial Results

Zimmer Biomet Announces Chief Financial Officer Transition

Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer